Capital Investment Management Inc. Lumira serves as Executive at Edesa Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Capital Investment Management Inc. Lumira has executed 8 insider transactions totaling $450.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 20, 2024 involved receiving (via award) 644,965 shares valued at $6.4M.
Capital Investment Management Inc. Lumira currently holds 993,651 shares of Edesa Biotech, Inc. (EDSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Investment Management Inc. Lumira has been a net buyer of EDSA stock. They have purchased $450.0K and sold $0 worth of shares.
Capital Investment Management Inc. Lumira's most recent insider trade was on Feb 20, 2024, when they sold 644,965 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted
| $10.00 |
| Discretionary |
| Nov 2, 2020 | EDSA | $257.4K | Exercise | 64,362 | $4.00 | Discretionary |
| Nov 2, 2020 | EDSA | $23.8K | Exercise | 5,952 | $4.00 | Discretionary |
| Jan 8, 2020 | EDSA | $38.1K | Purchase | 11,903 | $3.20 | Discretionary |
| Jan 8, 2020 | EDSA | $411.9K | Purchase | 128,722 | $3.20 | Discretionary |
| Jun 7, 2019 | EDSA | $0 | Award | 1,611,338 | $N/A | Discretionary |
| Jun 7, 2019 | EDSA | $0 | Award | 148,999 | $N/A | Discretionary |